2m 2m 2m 2m 2m 2m 2m
PLIANT THERAPEUT (PLRX)
NASDAQ
$1.16-$0.02 (-1.61%)
Price as of Jun 03, 2026 7:50 PM EDT- $78.0MMarket Cap
- -27.50%1-Year Change
- BiotechnologyIndustry
PLIANT THERAPEUT (PLRX)
$1.16-$0.02 (-1.61%)
PLRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.18 | ||
Change | -$0.04 (-3.33%) | ||
Open | $1.18 | ||
High | $1.20 | ||
Low | $1.14 | ||
Previous Close | $1.16 | ||
Volume | 1,589,205 | ||
30-Day Average Volume | 482,671 | ||
1-Week Change | -6.45% | ||
1-Month Change | -3.33% | ||
1-Year Change | -27.50% | ||
3-Year Change | -94.78% | ||
5-Year Change | -96.01% | ||
Fundamentals | |||
Shares Outstanding | 61.9M | ||
Total Assets | $202.6M | ||
Market Cap | $78.0M | ||
Enterprise Value | $57.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$20.0M | ||
Free Cash Flow | -$19.2M | ||
EBIT | -$20.0M | ||
EBITDA | -$19.8M | ||
Net Working Capital | $164.6M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue